Murphy-Chutorian Douglas 4
4 · Semler Scientific, Inc. · Filed Nov 18, 2025
Insider Transaction Report
Form 4
Murphy-Chutorian Douglas
DirectorCEO, interim CFO and Director
Transactions
- Gift
Common Stock
2025-11-17−54,594→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-17−125,000→ 0 totalExercise: $2.23Exp: 2026-02-17→ Common Stock (125,000 underlying) - Exercise/Conversion
Common Stock
2025-11-17$2.23/sh+125,000$278,750→ 125,000 total - Gift
Common Stock
2025-11-17+54,594→ 241,303 total(indirect: See Footnote) - Sale
Common Stock
2025-11-17$20.09/sh−57,669$1,158,570→ 67,331 total - Sale
Common Stock
2025-11-17$20.73/sh−12,737$264,038→ 54,594 total
Footnotes (5)
- [F1]The shares were sold by the reporting person to cover the exercise price and withholding taxes.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.57 to $20.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.57 to $21.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F4]Shares are held in a family trust over which Dr. Murphy-Chutorian is co-Trustee with his spouse, and with whom he shares voting and investment power over such securities.
- [F5]The shares underlying the option are fully vested and immediately exercisable.